VideoViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019WHO / Perspective on the Simplification Strategies - Phillippa Easterbrook, MD, FRCP, MPH, DTM&HerbrooView Video
HQHuma QureshiMDVideoViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019Pakistan’s Model for Care - Huma Qureshi, MDView Video
NDNaranjargal DashdorjMD, PhDVideoViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019Mongolia’s Model for Care - Naranjargal Dashdorj, MD, PhDView Video
JDMJean Damascene MakuzaMD, MScVideoViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019Rwanda’s Model for Care - Jean Damascene Makuza, MDView Video
KKKenneth KabagambeVideoViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019Uganda’s Experience - Kenneth KabagambeView Video
MHEManal Hamdy El-SayedMD, PhDVideoViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019Introductory Lecture - Manal El-Sayed, MD, PhDView Video
MTMark TyndallMD, ScD, FRCPCVideoViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019Canada’s Experience with Needle Exchange Programs - Mark Tyndall, MD, ScD, FRCPCallView Video
MNMichael NinburgMPAVideoViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019WHA / Community Perspective on the Need for Simplification - Michael NinburgView Video
VideoViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019Introduction of Simplification - Jordan Feld, MD, MPHView Video
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019Levofloxacin Target Attainment Analysis in MDR-TB Patients: Time is Ripe for Proactive TDM - Mathieu BolhuisView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019Drug Effect of Clofazimine on Persistent Mycobacteria Explain an Unexpected Increase of Bacterial Load in Patients - Alan FarajView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019Population Pharmacokinetics of Linezolid in TB Patients: Dosing Regimens Simulation and Target Attainment Analysis - Charles PeloquinView Slideset
